Airway allergy and viral infection

Asian Pacific Journal of Allergy and Immunology

Volumn 29, Issue 2, 2011, Pages 113-119

  Tantilipikorn, Pongsakorn ^a   Auewarakul, Prasert ^b  

^a Departments of Oto Rhino Laryngology   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Airway; Airway epithelium; Allergy; Asthma; Glucocorticoids; Inflammation; Influenza; Th2; Viral infection; Viral receptor; Virus

Indexed keywords

VIRUS RECEPTOR;

DISEASE EXACERBATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INFECTION RISK; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; OUTCOME ASSESSMENT; RESPIRATORY TRACT ALLERGY; REVIEW; RHINOVIRUS; RHINOVIRUS INFECTION; TH1 CELL; TH2 CELL; VIRUS INFECTION;

ANIMALS; ASTHMA; CLINICAL TRIALS AS TOPIC; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; RECEPTORS, PATTERN RECOGNITION; RESPIRATORY MUCOSA; RISK; RNA, VIRAL; TH1-TH2 BALANCE; VIRUS DISEASES;

EID: 79959347653     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Rindsjo E, Scheynius A. Mechanisms of IgE-mediated allergy. Exp Cell Research. 2010;316:1384-1389.
2. Curotto de Lafaille MA, Lafaille JJ, Graca L. Mechanisms of tolerance and allergic sensitization in the airways and the lungs. Curr Opin Immunol. 2010;22:616-622.
3. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007;8:191-197.
4. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198:1875-1886.
5. Kim JM, Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol Rev. 2006;212:86-98.
6. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med. 2002;8:1024-1032.
7. Finkelman FD, Hogan SP, Hershey GK, Rothenberg ME, Wills- Karp M. Importance of cytokines in murine allergic airway disease and human asthma. J Immunol. 2010;184:1663-1674.
8. Cobbold SP, Adams E, Farquhar CA, Nolan KF, Howie D, Lui KO, et al. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc Natl Acad Sci U S A. 2009;106:12055-12060.
9. Georas SN, Rezaee F, Lerner L, Beck L. Dangerous allergens: why some allergens are bad actors. Curr Allergy Asthma Rep. 2010;10:92-98.
10. Maneechotesuwan K, Wamanuttajinda V, Kasetsinsombat K, Huabprasert S, Yaikwawong M, Barnes PJ, et al. Der p 1 suppresses indoleamine 2, 3-dioxygenase in dendritic cells from house dust mite-sensitive patients with asthma. J Allergy Clin Immunol. 2009;123:239-248.
11. Hammad H, Lambrecht BN. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat Rev Immunol. 2008;8:193-204.
12. Kern RC, Conley DB, Walsh W, Chandra R, Kato A, Tripathi- Peters A, et al. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Am J Rhinol 2008;22:549-559.
13. Patadia M, Dixon J, Conley D, Chandra R, Peters A, Suh LA, et al. Evaluation of the presence of B-cell attractant chemokines in chronic rhinosinusitis. Am J Rhinol Allergy. 2010;24:11-16.
14. Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol. 2010;10:225-235.
15. Saenz SA, Taylor BC, Artis D. Welcome to the neighbourhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev. 2008 Dec;226:172-190.
16. Holgate ST, Roberts G, Arshad HS, Howarth PH, Davies DE. The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. Proc Am Thorac Soc. 2009 Dec;6(8):655-659.
17. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature. 2002 Jul 25;418(6896):426-430.
18. Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, Holgate ST, et al. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J. 2000 Jul;14(10):1362-1374.
19. Gern JE, Busse WW. Relationship of viral infections to wheezing illnesses and asthma. Nat Rev Immunol. 2002;2:132-138.
20. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12204-12209.
21. Sly PD, Kusel M, Holt PG. Do early-life viral infections cause asthma? J Allergy Clin Immunol. 2010;125:1202-1205.
22. Schwarze J. Lung dendritic cells in respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J. 2008;27(10 Suppl):89-91.
23. Kim EY, Battaile JT, Patel AC, You Y, Agapov E, Grayson MH, et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med. 2008;14:633-640.
24. Zhang G, Rowe J, Kusel M, Bosco A, McKenna K, de Klerk N, et al. Interleukin-10/interleukin-5 responses at birth predict risk for respiratory infections in children with atopic family history. Am J Respir Crit Care Med. 2009;179:205-211.
25. Subrata LS, Bizzintino J, Mamessier E, Bosco A, McKenna KL, Wikstrom ME, et al. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol. 2009;183:2793-2800.
26. Tacon CE, Wiehler S, Holden NS, Newton R, Proud D, Leigh R. Human rhinovirus infection up-regulates MMP-9 production in airway epithelial cells via NF-κB. Am J Respir Cell Mol Biol. 2010;43:201-209.
27. Kuo C, Lim S, King NJ, Johnston SL, Burgess JK, Black JL, et al. Rhinovirus infection induces extracellular matrix protein deposition in asthmatic and non-asthmatic airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2011; 300: 951-957.
28. Jankowska R, Szalaty H, Nyczka J. Interferon synthesis by peripheral blood leukocytes of patients with bronchial asthma. Arch Immunol Ther Exp (Warsz). 1989;37:509-512.
29. Jankowska R, Szalaty H, Malolepszy J, Sypula A, Zielinska- Jenczylik J. Production of interferon by leukocytes from patients with atopic and nonatopic asthma. Arch Immunol Ther Exp (Warsz). 1988;36:523-526.
30. Hassantoufighi A, Oglesbee M, Richter BW, Prince GA, Hemming V, Niewiesk S, et al. Respiratory syncytial virus replication is prolonged by a concomitant allergic response. Clin Exp Immunol. 2007;148:218-229.
31. Anderson VE, Nguyen Y, Weinberg JB. Effects of allergic airway disease on mouse adenovirus type 1 respiratory infection. Virology. 2009;391:25-32.
32. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201:937-947.
33. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006;12:1023-1026.
34. Kang DH, Coe CL, McCarthy DO, Jarjour NN, Kelly EA, Rodriguez RR, et al. Cytokine profiles of stimulated blood lymphocytes in asthmatic and healthy adolescents across the school year. J Interferon Cytokine Res. 1997;17:481-487.
35. Royer PJ, Emara M, Yang C, Al-Ghouleh A, Tighe P, Jones N, et al. The mannose receptor mediates the uptake of diverse native allergens by dendritic cells and determines allergen-induced T cell polarization through modulation of IDO activity. J Immunol. 2010;185:1522-1531.
36. Nakazato J, Kishida M, Kuroiwa R, Fujiwara J, Shimoda M, Shinomiya N. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol. 2008;19:605-613.
37. Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T, et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A. 2008;105:13562-13567.
38. Thongratsakul S, Suzuki Y, Hiramatsu H, Sakpuaram T, Sirinarumitr S, Poolkhet C, et al. Avian and human influenza A virus receptors in trachea and lung of animals. Asian Pac J Allergy Immunol. 2010;28:294-301.
39. Canonica GW, Ciprandi G, Pesce GP, Buscaglia S, Paolieri F, Bagnasco M. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol. 1995;107:99-102.
40. Suptawiwat O, Tantilipikorn P, Boonarkart C, Lumyongsatien J, Uiprasertkul M, Puthavathana P, et al. Enhanced susceptibility of nasal polyp tissues to avian and human influenza viruses. PLoS One.5(9):12973.
41. Qvarnberg Y, Valtonen H, Laurikainen K. Intranasal beclomethasone diproprionate in the treatment of common cold. Rhinology. 2001;39:9-12.
42. Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci. 2004:1024; 138-146.
43. Gustafson LM, Proud D, Hendley O, Hayden FG, Gwaltney JM. Oral prednisolone therapy in experimental rhinovirus infections. J Allergy Clin Immunol. 1996;97:1009-1014.
44. Puhakka T, Makela MJ, Malmstrom K, Uhari M, Savolainen J, Terho EO, et al. The common cold: effects of intranasal fluticasone propionate treatment. J Allergy Clin Immunol. 1998;101:726-731.
45. Nathan RA, Berger W, Yang W, Cheema A, Silvey M, Wu W, et al. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhintis. Ann Allergy Asthma Immunol. 2008;100:497-505.
46. Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkausklene B, Van Oene C, et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 2007;62(9):1078-1084.
47. Tantilipikorn P, Thanaviratananich S, Chusakul S, Benjaponpitak S, Fooanant S, Chintrakarn C, et al. Efficacy and safety of once daily fluticasone furoate nasal spray for treatment of irritant (nonallergic) rhinitis. Open Resp Med J. 2010;4:92-99.